July 29, 2013
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory organ to the health minister, on July 27 recommended approval for Kyorin Pharmaceutical’s bronchial asthma treatment Flutiform (fluticasone propionate + formoterol fumarate), and other products. Flutiform,...read more